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Abstract: In poultry production, gut microbiota (GM) plays a pivotal role and influences different
host functions related to the efficiency of production performances. Antimicrobial (AM) use is
one of the main factors affecting GM composition and functions. Although several studies have
focused their attention on the role of AMs as growth promoters in the modulation of GM in broilers,
the consequences of higher AM concentrations administered during prophylactic treatments need
to be better elucidated. For this purpose, 16S rRNA gene sequencing was performed to evaluate
the impact of different prophylactic AM protocols on the composition and diversity of the broiler
GM. Diversity analysis has shown that AM treatment significantly affects alpha diversity in ileum
and beta diversity in both ileum and caecum. In ileal samples, the Enterobacteriaceae family has
been shown to be particularly affected by AM treatments. AMs have been demonstrated to affect
GM composition in broiler. These findings indicate that withdrawal periods were not enough for
the restoral of the original GM. Further studies are needed for a better elucidation of the negative
effects caused by an altered GM in broilers.
Keywords: prophylaxis; coccidiostat; broiler; 16S rRNA sequencing; ileum; caecum
1. Introduction
The intestinal microbiota is a complex microbial community that has established a sym-
biotic relationship with its animal host [1]. It is well known that gut microbiota (GM) plays
an essential role as a first-line defense in the intestinal mucosal barrier [2]. This microbial
community has evolved together with the animal host and through the colonization resis-
tance ensures the prevention of animal health from the arousal of intestinal infectious dis-
ease [2,3]. In poultry production, GM plays a pivotal role and its several functions have been
related to the efficiency of production performances [4–6]. Furthermore, GM influences
different host functions, e.g., digestion of nutrients, immunity, and metabolism [1,7]. It has
been demonstrated that GM perturbations could negatively affect intestinal health and lead
to severe health consequences for animals, but also to economic losses for the farmer [7–9].
Antimicrobial (AM) use is one of the main factors affecting GM composition and functions.
In recent years, there has been an increasing concern about antimicrobials resistance (AMR)
and the role of AM use in the spreading of AMR, and the selection of multi-drug-resistant
bacteria [10,11]. On the other hand, AM use leads to long-lasting disturbances of the com-
mensal GM and may negatively affect broiler physiology [12]. Moreover, the broiler GM
varies among the different intestinal tracts and its composition reflects their different func-
tions [7]. Several studies focused their attention on the role of AMs as growth promoters in
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the modulation of GM in broilers [13–15], but the consequences of higher AM concentra-
tion on GM, e.g., during prophylactic treatments, need to be better elucidated. Therefore,
the main aim of this study was to evaluate the impact of different prophylactic AM pro-
tocols on the composition and diversity of the broiler GM by 16S rRNA gene sequencing
technology. In addition, we evaluated the different impact of AM treatment on the ileum
and caecum microbiota.
2. Results
2.1. 16S rRNA Diversity Analysis
A total of 84 samples were analyzed both for ileal (n = 42) and caecal (n = 42) microbiota
by 16S rRNA sequencing. A total of 8,036,623 raw reads (2 × 300 bp) were obtained
after sequencing, with an average value of 95,674 reads/sample. After joint and quality
filtering, a total of 4,963,263 reads passed the filters applied through the DADA2 plugin
in the QIIME2 software package (https://qiime2.org; version: 2019.10), with an average
value of 95,361 reads/sample. Following primer trimming and raw read quality filtering,
ileal and caecal samples were analyzed separately. In order to avoid biases due to different
sequencing depths, ileal samples and caecal samples were rarefied at 31,100 reads and
5600 reads, respectively; one sample from ileum was excluded from further analyses due to
a low read count. After assigning taxonomies, a total of 3421 unique operational taxonomic
units (OTUs) at 99% nucleotide sequence identity were identified in caecum samples,
while 1153 unique OTUs were identified in ileum samples.
Alpha diversity analysis has shown that AM treatments have different consequences
on ileum and caecum microbiota. Considering caecal samples, Pielou’s evenness (H = 5.38;
p = 0.5) and Faith’s phylogenetic diversity (H = 7.69; p = 0.26) indicated no significant
differences between samples. Instead, ileum samples were characterized by alpha diversity
metrics statistically different with Pielou’s evenness (H = 13.53; p = 0.03) and Faith’s
phylogenetic diversity (H = 13.12; p = 0.04).
In addition, the Permutational Multivariate Analysis of Variance (PERMANOVA) test
has shown that beta diversity metrics were always statistically different between groups
(p = 0.001 for caecum and p = 0.002 for ileum). Principal Coordinate Analysis (PCoA) plots
were generated both for caecum and ileum using beta diversity metrics and are presented
in Figure 1 (caecum) and Figure 2 (ileum).
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Figure 1. PCoA plot of beta diversity analysis of caecal samples. Amoxicillin group (AMX) (red), 
amoxicillin + diclazuril group (AMX + DCZ) (blue), thiamphenicol group (THP) (purple), thiam-
phenicol + diclazuril group (THP + DCZ) (grey), sulfadiazine + trimethoprim group (TRIM) 
(brown), diclazuril group (DCZ) (orange) and control group (K) (green). 
 
Figure 2. PCoA plot of beta diversity analysis of ileal samples. Amoxicillin group (AMX) (red), 
amoxicillin + diclazuril group (AMX + DCZ) (blue), thiamphenicol group (THP) (purple), thiam-
phenicol + diclazuril group (THP + DCZ) (grey), sulfadiazine + trimethoprim group (TRIM) 
(brown), diclazuril group (DCZ) (orange) and control group (K) (green). 
Figure 1. PCoA plot of beta diversity analysis of caecal samples. Amoxicillin group (AMX) (red),
amoxicillin + dic azuril group (AMX + DCZ) (blue), th amphenicol group (THP) (purple), thiampheni-
col + diclazuril group (THP + DCZ) (grey), sulfadiazine + trimethoprim group (TRIM) (brown),
diclazuril group (DCZ) (orange) and control group (K) (green).
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amoxicillin + diclazuril group (AMX + DCZ) (blue), thiamphenicol group (THP) (purple), thiam-
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Figure 2. PCoA plot of beta diversity analysis of ileal samples. Amoxicillin group (AMX) (red), amox-
icillin + diclazuril group (AMX + DCZ) (blue), thiamphenicol group (THP) (purple), thiamphenicol +
diclazuril group (THP + DCZ) (grey), sulfadiazine + trimethoprim group (TRIM) (brown), diclazuril
group (DCZ) (orange) and control group (K) (green).
2.2. 16S rRNA Taxonomy Analysis
For caecal samples, the dominant phyla were in order: Firmicutes, Bacteroides, Pro-
teobacteria, an unassigned bacterial phylum, and Cyanobacteria. At the family level, OTUs
were assigned to an unassigned family of Clostridiales order, Ruminococcaceae, Bacteroidaceae,
Rikinellaceae, and Barnesiellaceae. Among ileal samples, the main five phyla were in order:
Firmicutes, Proteobacteria, Bacteroides, Cyanobacteria, and an unassigned bacterial phylum.
At the family level, the main taxa identified were, respectively: Turibacteriaceae, an unas-
signed family of Clostridiales order, Enterococcaceae, Clostridiaceae, and Peptostreptococcaceae.
Relative abundances of the aforementioned taxa are shown in bar plots of Figure 3 for
caecum and Figure 4 for ileum.
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Two-way ANOVA was performed on the abundance of OTU values belonging to the
aforementioned phyla and families. Related p values are presented in Table 1. Detailed
results of the two-way ANOVA are available in Table S1.
The results show that an effect of the studied taxa was always significant on the
total variance of the samples. Box plots are shown in Figure 5 (caecum) and Figure 6
(ileum). Most intriguingly, however, in Tukey’s post-test the ileal families Enterococcaceae
have been shown to be significantly overrepresented in our samples in amoxicillin group
(AMX) (p-value = 0.004) and in thiamphenicol group (THP) (p-value < 0.0001) groups in
comparison to control group K.
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3. Discussion
In the last two decades, AM use in veterinary medicine has undergone several changes
and limitations mainly considering the threat of AMR. Prophylactic and therapeutic uses
of AMs are still permitted, even if their way of use has been continuously revised in
compliance with national and international laws. Poultry production is particularly con-
cerned by these changes. It is well known that broiler GM is a favorable environment
for the dissemination of AMR genes between commensal and pathogenic bacteria [16].
Moreover, the selective pressure of AM treatments can enforce the selection of resistant
bacteria worsening the AMR threat in poultry productions [17]. On the other hand, any
modifications of GM, also known as dysbiosis, could alter broiler physiology and increase
susceptibility to infectious disease, or also metabolic and inflammatory dysfunctions [2].
In our study, we aim to investigate the impact of different treatments on broiler
GM in ileum and caecum. Several studies have described the microbial communities
that colonized the two different intestinal tracts [7,18]. Their microbial composition re-
flects the different functions of these organs, and their relationship has brought mutual
benefits for each other. In particular, the ileum is the main site of nutrient absorption
and it is generally colonized by bacteria that influence nutrients availability and host
metabolism [6,7]. For example, Lactobacillus spp. is one of the main represented genera and
its functions have been related to the production of essential vitamins, but also the recycling
of intestinal bile acids [7]. On the other side, caecum is an important site of starch fermen-
tation, water absorption, and urea recycling and these activities are strictly dependent on
the metabolic capacity of caecum microbiota [6,19]. Caecal GM has always been reported
as the one with the highest richness and abundance in bacterial composition and Bacteroides
spp., Ruminococcus spp., and Faecalibacterium spp. are the main genera that have been
found [7,18,20]. Our results highlighted that different AM treatments have a diverse impact
on ileal and caecal communities.
Considering alpha diversity metrics, which are indicators of the abundance of a micro-
bial community [21], our results show significantly different Pielou’s evenness (p = 0.03 for
ileum; p = 0.5 for caecum) and Faith’s phylogenetic diversity (p = 0.04 for ileum; p = 0.26
for caecum) only in ileum. These results can suggest that the withdrawal periods could
be not enough for the restoral of the abundance of microbial communities in the ileum.
It is well known that broiler caecum harbors the richest and most diverse microbiota in
comparison with other intestinal tracts [22–24]. Moreover, Mohd Shaufi et colleagues [25]
have shown that caecum microbiota presented a significant difference in the expression
of the bacterial colonization pathway (e.g., motility proteins, two-component system, and
bacterial system). All these considerations can help to explain the alpha diversity metrics
not affected in caecal samples.
On the other hand, beta diversity metrics are significantly affected by AM treatment
(p = 0.001 in the caecum and p = 0.002 in the ileum). Beta indexes describe compositional
changes between different microbial communities [21]. As expected, the six AM protocols
caused different changes in GM of ileum and caecum. These significant results can also
be visualized in PCoA plots (Figures 1 and 2), where caecal control samples are clearly
separated from the others. Otherwise, the ileal PCoA plot shows less separation between
groups probably due to a lower diversity of ileal GM than the caecal one, as mentioned
above. First, we can explain this result with the different broad-spectrum action of amox-
icillin, thiamphenicol, and trimethoprim–sulfadiazine. In addition, the association with
diclazuril can modulate the AM activity against gut bacteria. In our case, sulfadiazine–
trimethoprim is not active against bacteria belonging to Enterococcus and Pseudomonas
genera [26]. On the contrary, thiamphenicol and amoxicillin have a wider antibacterial ac-
tivity than sulfadiazine–trimethoprim. Amoxicillin is often associated with clavulanic acid
to improve antibacterial activity against β-lactamases producers [27]. In Italy, amoxicillin
is only permitted as monotherapy in poultry production, and several pieces of evidence
support that broiler GM is a reservoir of different β-lactamases producing bacteria, e.g.,
Extended-Spectrum-Beta-Lactamases producing Enterobacteriaceae [28,29].
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In our study, taxonomy results were analyzed by two-way ANOVA to verify if a
differentially abundant taxon related to the different AM treatment groups existed. The ex-
tremely abundant phylum in ileal samples was Firmicutes, and, due to this high prevalence,
the phyla significantly affected the variance in our samples both in ileum and caecum.
This result is in accordance with other published works, where Firmicutes is the main
phyla in ileum accounting for more than 90% of the total OTUs and also the dominant one
in caecum but less frequent than other phyla [4,7]. Moreover, in ileal samples, the Enterococ-
caceae family was shown to be significantly affected by AM treatments in groups AMX and
THP. The increase in bacteria belonging to this family may be due to an increased resistance
against amoxicillin and thiamphenicol. Enterococcaceae are known to present a naturally
reduced susceptibility to penicillins, due to the expression of low-affinity penicillin-binding
proteins [30,31]. Resistance to phenicols, instead, has been recently described in Enterococ-
cus spp. harboring multi-drug resistance plasmids isolated from both animal and human
samples [30,32].
4. Materials and Methods
4.1. Animals and Samples Collection
A total of 240 male broilers (Ross 308) were reared under the same conditions in
the chicken broiler farm facility of the Department of Veterinary Sciences of the University
of Turin as previously reported [33]. Briefly, chicks were randomly allocated into 7 groups.
During production cycles, six groups received a different antimicrobial prophylactic pro-
gram: thiamphenicol (Tirsan O.S. 200 mg/g) (THP), amoxicillin (Amoxid Polv 1430 g)
(AMX), sulfadiazine + trimethoprim (Trimethosulfa orale) (TRIM), thiamphenicol (Tirsan
O.S. 200 mg/g) + diclazuril (Coxiril) (THP + DCZ), amoxicillin (Amoxid Polv 1430 g)
+ diclazuril (Coxiril) (AMX + DCZ), and diclazuril (Coxiril) (DCZ). Untreated animals
were used as a control group (K). Chickens received a starter diet from 0 to 25th day and
a grower diet from 26th to 58th day of rearing and AMs were administered in both these
periods. Water and feed were provided ad libitum during the whole cycle. The envi-
ronmental conditions (lighting programs, temperature, relative humidity, and ventilation
rates) were regulated accordingly to the Ross broiler management guidelines. AMs were
administered via drinking water. Detailed prophylactic protocols are available in Table 2.
The withdrawal periods were respected before slaughtering. At the end of the rearing cycle
(58 days), 120 broilers were regularly slaughtered, in particular, 15 animals per each treated
group and 30 animals of the untreated group. Intestinal contents from ileum and caecum
were aseptically collected. Samples were immediately stored at −80 ◦C.
Table 2. Antimicrobial (AM) prophylactic treatment protocols applied during broiler rearing. The animals were divided into seven
groups and slaughtered after a withdrawal period.
Group AMs Dosing Protocols per os Time-Lapse of Treatments(Rearing Days) Withdrawal (Days)
AMX Amoxicillin 30 mg·kg−1 b.w. twice/day 20–22/53–56 1
AMX + DCZ AmoxicillinDiclazuril






THP Thiamphenicol 65 mg·kg−1 b.w./day 23–25/47–51 6











DCZ Diclazuril 1 mg/kg 0–52 5
K - - - -
b.w.: body weight.
Antibiotics 2021, 10, 146 8 of 10
4.2. DNA Extraction and 16S rRNA Sequencing
Genomic DNA was isolated from 6 samples, randomly selected in each group, both
for ileal and caecal content. DNAzol (Thermo Fisher Scientific, Waltham, MA, USA) and
DNeasy PowerClean Pro Cleanup Kit (QIAGEN, Hilden, Germany) were, respectively,
used for DNA extraction and purification according to the manufacturer’s procedures.
DNA was quantified using a Nanodrop spectrophotometer (Thermo Fisher Scientific,
Waltham, MA, USA). Library preparation and 16S rRNA gene sequencing were performed
by an external laboratory (BMR Genomics, Padova, Italy). The variable V3 and V4 regions
were amplified with universal prokaryote primers Pro341F and Pro805R [34]. A Nex-
tera XT Index kit (Illumina, San Diego, CA, USA) was used for libraries’ preparation.
Finally, amplicons were sequenced with the Illumina MiSeq platform using a 2 × 300 bp
paired-end protocol.
4.3. Bioinformatic Analyses
Raw reads were divided according to their intestinal origin (ileum and caecum) and
analyzed separately with the same bioinformatic pipeline. The quality of raw reads was
checked with FastQC v. 0.11.9 software. Then, raw reads were processed following Qiime2
v. 2019.10 pipeline [35]. Primers were trimmed using Cutadapt [36]. Low-quality reads
with a q-score < 20 were removed. After trimming and filtering steps, clean reads were
processed with DADA2 [16]. The amplicon sequence variant (ASV) table was used for
generating the rooted and unrooted phylogenetic trees. Afterwards, alpha (Pielou’s even-
ness and Faith’s phylogenetic Diversity) and beta diversity indexes (unweighted UniFrac,
weighted UniFrac, Jaccard, and Bray-Curtis distances) were determined. PCoA plots were
generated using Emperor tool in Qiime2. Statistical analyses were conducted using Qiime2
plugins. A pairwise Kruskall–Wallis test and nonparametric Permutational Multivariate
Analysis of Variance (PERMANOVA) tests were conducted, respectively, for alpha and beta
metrics. The alpha-rarefaction curve was generated to understand if the sequencing depth
was enough to describe all microbial communities. Finally, taxonomy was assigned to the
obtained ASV table using the Greengenes database clustered at 99% identity. The Green-
genes database was previously trained to the region targeted by sequencing primers. Box
plots were generated for taxonomy results visualization.
4.4. Taxonomy Analyses
Data from the taxonomic assignment of OTUs were tested for differentially abundant
taxa for both phyla and families. Statistical analyses were performed by two-way ANOVA
using GraphPad Prism v.6 (GraphPad Software, San Diego, CA, USA). The two effects
evaluated were the AM treatment group (AMX, AMX + DCZ, THP, THP + DCZ, TS,
DCZ, and K) and the top five phyla and families represented in ileal and caecal samples.
We tested multiple comparison corrections with Tukey’s test when two-way ANOVA
showed a p-value < 0.05 or a significant interaction was revealed.
5. Conclusions
In conclusion, our study demonstrates that AM prophylactic protocols, as they are
normally adopted in poultry production, are responsible for GM compositional alterations.
Moreover, the respected withdrawal periods were not enough for the restoral of a GM
similar to the K group’s one. This conclusion could seem to be in accordance with Elokil
et al. [37], who recently published a paper where adult broilers had negative consequences
on GM after enrofloxacin administration. However, this study is not comparable with ours
because the age of broilers and the applied AM protocols are different. These changes to
GM can lead to negative consequences for broilers, and, in particular, future studies should
focus on how GM alterations affect host intestinal physiology. Moreover, further investi-
gations focusing on the selective pressure applied by AM treatments on the expression of
AMR genes in GM need to be carried out.
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